Filing Details
- Accession Number:
- 0001225208-15-017259
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-19 11:16:25
- Reporting Period:
- 2015-08-17
- Filing Date:
- 2015-08-19
- Accepted Time:
- 2015-08-19 11:16:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
105770 | West Pharmaceutical Services Inc | WST | Fabricated Rubber Products, Nec (3060) | 231210010 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1260426 | J William Federici | 530 Herman O. West Drive Exton PA 19341 | Sr. Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-17 | 52,678 | $22.49 | 256,360 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-08-17 | 52,678 | $59.72 | 203,682 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-08-17 | 52,678 | $22.49 | 52,678 | $22.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-02-27 | 2018-02-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,026 | Indirect | By Savings Plan |
Common Stock | 16,274 | Indirect | Non-Qualified Deferred Compensation Plan |
Footnotes
- Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.